How to spot bias and other potential problems in randomised controlled trials

Lewis S C; Warlow C P; Lewis, S C; Warlow, C P
February 2004
Journal of Neurology, Neurosurgery & Psychiatry;Feb2004, Vol. 75 Issue 2, p181
Academic Journal
journal article
No abstract available.


Related Articles

  • Systematic reviews in health care: Assessing the quality of controlled clinical trials. Juni, Peter; Altman, Douglas G; Egger, Matthias // BMJ: British Medical Journal (International Edition);7/7/2001, Vol. 323 Issue 7303, p42 

    Discusses the concept of study quality and the methods used to assess quality of randomised controlled trials. Validity of the findings as a dimension of quality; Bias in clinical trials, such as selection bias and performance bias; Applicability of the results of a study to other populations...

  • Improving recruitment of older people to clinical trials: use of the cohort multiple randomised controlled trial design. CLEGG, ANDREW; RELTON, CLARE; YOUNG, JOHN; WITHAM, MILES // Age & Ageing;Jul2015, Vol. 44 Issue 4, p547 

    There is widespread evidence of under-recruitment of older people to research studies, notably randomised controlled trials of interventions. Study exclusion criteria, ethical dilemmas, patient preference, risk of bias and challenges for treatment comparisons are particular problems faced by...

  • Negative Control Outcomes. Arnold, Benjamin F.; Ercumen, Ayse // JAMA: Journal of the American Medical Association;12/27/2016, Vol. 316 Issue 24, p2597 

    The authors present their thoughts on how negative control outcomes can be used to identify bias in randomized trials and epidemiological studies. They discuss how negative control outcomes compare to exposures in a randomized trial, noting that negative control outcomes are not controlled by...

  • Randomised controlled trials. Geddes, John // British Journal of Psychiatry;Jul2014, Vol. 205 Issue 1, p43 

    A definition of randomised controlled trials is presented.

  • Randomised trials in context: practical problems and social aspects of evidence-based medicine and policy. Pearce, Warren; Raman, Sujatha; Turner, Andrew // Trials;9/5/2015, Vol. 16 Issue 1, p1 

    Randomised trials can provide excellent evidence of treatment benefit in medicine. Over the last 50 years, they have been cemented in the regulatory requirements for the approval of new treatments. Randomised trials make up a large and seemingly high-quality proportion of the medical...

  • What can we learn from observational studies of oseltamivir to treat influenza in healthy adults? Freemantle, Nick; Calvert, Mel // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;12/12/2009, Vol. 339 Issue 7734, p1352 

    The article investigates the limited value of studies of the use of the antiviral drug oseltamivir to treat influenza in healthy adults identified by Roche. It discusses the problems associated with randomised controlled trials as a basis for examining the effects of the drug. It examines the...

  • Need for expertise based randomised controlled trials. Devereaux, P. J.; Bhandari, Mohit; Clarke, Mike; Montori, Victor M.; Cook, Deborah J.; Yusuf, Salim; Sackett, David L.; Cinà, Claudio S.; Walter, S. D.; Haynes, Brian; Scjünemann, Holger J.; Norman, Geoffrey R.; Guyatt, Gordon H. // BMJ: British Medical Journal (International Edition);1/8/2005, Vol. 330 Issue 7482, p88 

    Suggests an alternative to the use of randomised controlled trials to evaluate non-pharmacological interventions such as surgery. Belief that expertise based trials are the solution; Problems with validity of conventional randomised controlled trials outside of drug therapies; Potential problems...

  • Theory of planned behaviour variables and objective walking behaviour do not show seasonal variation in a randomised controlled trial. Williams, Stefanie L.; French, David P. // BMC Public Health;2014, Vol. 14 Issue 1, p1 

    Background Longitudinal studies have shown that objectively measured walking behaviour is subject to seasonal variation, with people walking more in summer compared to winter. Seasonality therefore may have the potential to bias the results of randomised controlled trials if there are not...

  • Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium. Kai-Michael Beeh; Beier, Jutta; Donohue, James F. // Respiratory Research;Jun2012, Vol. 13 Issue 6, p1 

    Randomised, double-blind, controlled trials are considered the gold standard for evaluating a pharmacological agent, as they minimise any potential bias. However, it is not always possible to perform double-blind trials, particularly for medications delivered via specific devices, e.g. inhalers....

  • Impact of the demand for 'proxy assent' on recruitment to a randomised controlled trial of vaccination testing in care homes. Whelan, Paul James; Walwyn, Rebecca; Gaughran, Fiona; Macdonald, Alastair // Journal of Medical Ethics;Jan2013, Vol. 39 Issue 1, p36 

    Legal frameworks are in place to protect those who lack the capacity to consent to research, such as the Mental Capacity Act in the UK. Assent is sought instead from a proxy, usually a relative. However, the same legislation may, perversely, affect the welfare of those who lack capacity and of...


Read the Article


Sign out of this library

Other Topics